The Care222 module from Ushio Inc - far UV-C light targets occupied rooms

Reviewed: ad hoc news Classics & Longseller desk. Edited and checked on 2026-06-28, 06:55. Details in the imprint.

The Care222 module from Ushio Inc sits quietly above the doorway, casting a cool, invisible cone of far UV-C light where people breathe and talk. You only notice it when the small status LED glows in a tidy line and the ceiling looks a little more crowded than usual.

What Care222 actually does

Care222 is Ushio's filtered 222 nm far UV-C light source designed to inactivate viruses and bacteria directly in occupied rooms, from hospital corridors to open-plan offices. The module limits emission to a narrow band that studies have linked to reduced penetration into human skin and eyes.

Product manager Yukihiro Takahashi likes to describe Care222 as "a disinfection layer that runs silently above everyday life," aiming to cut airborne pathogen load without changing how people move through a space.

How the module is built

Inside the Care222 housing sits an excimer lamp with a dedicated optical filter stack that sharply cuts longer UV wavelengths, paired with a simple reflector geometry to shape the beam. Installers see a compact, rectangular unit that screws into existing infrastructure without needing a bulky ballast box.

The housing has a slightly textured, matte finish that feels robust when you run a hand along the edge, more like industrial lighting than delicate medical gear, which suits schools and stations where maintenance teams do not baby the fixtures.

Where it is used today

Hospitals and clinics were the earliest adopters, mounting Care222 modules along waiting-room ceilings and over triage desks where aerosols concentrate. In that setting, the promise is simple: a steady, quiet reduction of pathogen load without the smell or residues of chemical cleaning.

More recently, facility managers in transport hubs and universities have trialed the technology in lecture halls and walkways, often pairing modules with CO2 monitors and ventilation upgrades to build a layered protection concept.

Safety limits and standards

Care222 operates within exposure guidelines that Japanese and international bodies have drawn up for far UV-C, using timing controls and geometry to keep cumulative dose below threshold values over a typical working day. The lamp cycles are tuned so that a person standing under the beam for hours does not exceed those limits.

Ushio emphasizes that Care222 is not an excuse to abandon ventilation and masking policies in critical environments, but rather a technical supplement that works in the background while staff follow standard infection control protocols.

Everyday experience and noise

In daily use, the module adds no noticeable heat and almost no fan noise; a nurse in a corridor mainly hears the air handlers and footsteps, not the lamp. The most immediate sign that the unit is active is the small indicator light and occasionally a faint, electronic click as control electronics step through a duty cycle.

Because the radiation sits outside the visible spectrum, there is no harsh blue wash or flicker, which helps acceptance among patients who may already feel on edge in clinical spaces.

Installation and maintenance

Care222 ships as a module that integrators can build into bespoke fixtures or retrofit into existing luminaires, which makes it flexible for architects who do not want a medical device aesthetic dominating the ceiling grid. Electricians treat it much like an advanced lighting component with an additional control line.

Maintenance routines are closer to those of specialty lamps than commodity LEDs, with lamp replacement intervals tracked by run-time counters rather than simple calendar dates, and filters inspected to ensure their spectral cutoff has not drifted.

Cost positioning and buyers

Pricing for Care222 sits comfortably above conventional UV lamps, reflecting the excimer technology and filtration design, so purchasing decisions usually involve infection control committees rather than just the lighting department. That moves the product squarely into a B2B environment where total cost of ownership matters more than sticker price.

Buyers weigh the module against alternatives such as upper-room UV, HEPA filtration upgrades, and portable air cleaners, often choosing a mix depending on room height, occupancy patterns, and budget cycles.

How it compares with old-school UV

Traditional germicidal UV at 254 nm remains effective but demands that rooms be empty or that fixtures be mounted so far above head height that they largely treat the ceiling air. Care222, by contrast, is purpose-built to operate with people present, which is the core part of its appeal.

In practical terms, that means facility managers can keep treatment running through visiting hours or class sessions, rather than reserving it for overnight cleaning cycles when nobody is around.

Limits and critical questions

There are still open questions, including how far UV-C performs against different pathogen types and how exposures accumulate in special populations like infants or immunocompromised patients. Early adopters know they are betting on a technology that regulatory science is still mapping out in detail.

That is why most deployments combine Care222 with conservative safety margins, ongoing monitoring, and clear signage that explains to staff what the light does and does not promise.

Why Ushio sticks with light

For Ushio, Care222 fits into a decades-long focus on specialty light sources, from cinema projectors to industrial lamps for semiconductor manufacturing. The company leans on that heritage to argue that controlling wavelength, intensity, and beam shape is part of its core competence.

Chief executive Koji Naito has framed the product line as an example of how Ushio wants to use photonics not just for manufacturing and entertainment, but also for public health applications that stay visible on the balance sheet.

Context and Ushio shares

Overall, Care222 has grown into a quiet pillar of Ushio's specialty portfolio, especially in healthcare and public infrastructure projects across Japan and selected international markets. The product does not dominate headlines but anchors a consistent stream of orders and retrofit work.

Ushio shares (ISIN JP3156400008) are listed on the Tokyo Stock Exchange, and the Care222 platform remains one of the product families that analysts watch when they assess how much specialty lighting contributes to the Ushio share price over time.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.

en | JP3156400008 | USHIO | boerse | 69644004 | bgmi